Aptevo Therapeutics (APVO) Short Interest Ratio & Short Volume → The Most Dangerous Time for 401k Owners (From Birch Gold) (Ad) Free APVO Stock Alerts $0.83 +0.04 (+5.06%) (As of 06/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Aptevo Therapeutics Short Interest DataCurrent Short Interest54,000 sharesPrevious Short Interest268,200 sharesChange Vs. Previous Month-79.87%Dollar Volume Sold Short$43,632.00Short Interest Ratio0.1 Days to CoverLast Record DateMay 15, 2024Outstanding Shares4,080,000 sharesFloat Size4,070,000 sharesShort Percent of Float1.33%Today's Trading Volume132,850 sharesAverage Trading Volume527,917 sharesToday's Volume Vs. Average25% Short Selling Aptevo Therapeutics ? Sign up to receive the latest short interest report for Aptevo Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAPVO Short Interest Over TimeAPVO Days to Cover Over TimeAPVO Percentage of Float Shorted Over Time Ad TradingTips3 Dirt-Cheap Stocks You Can’t Afford to Ignore Often, investors will overlook stocks just because they're cheap. It's a common thought that a cheap price tag means that something must be wrong with the company. But this couldn't be further from the case in many instances.Get your FREE look at these THREE companies right here. Aptevo Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202454,000 shares $43,632.00 -79.9%1.3%0.1 $0.81 4/30/2024268,200 shares $190,609.74 +84.2%16.8%0.3 $0.71 4/15/2024145,600 shares $114,004.80 +324.5%9.1%0.6 $0.78 3/31/202434,300 shares $160,867.00 +18.7%5.1%0.3 $4.69 3/15/202428,900 shares $156,638.00 +725.7%5.5%0.3 $5.42 2/29/20243,500 shares $26,180.00 -82.1%N/A0 $7.48 Get the Latest News and Ratings for APVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202419,600 shares $3,077.20 +17.4%N/A0.1 $0.16 1/31/202416,700 shares $2,715.42 -78.8%N/A0 $0.16 1/15/202478,900 shares $12,545.10 -61.3%N/A0.2 $0.16 12/31/2023203,900 shares $36,905.90 +253.4%N/A0.3 $0.18 12/15/202357,700 shares $9,924.40 -46.0%N/A0.1 $0.17 11/30/2023106,800 shares $19,971.60 +297.0%N/A0.2 $0.19 11/15/202326,900 shares $4,976.50 -74.2%N/A0.1 $0.19 10/31/2023104,300 shares $29,485.61 -19.3%N/A0.2 $0.28 10/15/2023129,200 shares $41,344.00 +7.4%N/A0.3 $0.32 9/30/2023120,300 shares $39,699.00 +161.5%N/A0.4 $0.33 9/15/202346,000 shares $18,446.00 -46.6%N/A0.1 $0.40 8/31/202386,200 shares $37,928.00 +176.3%N/A0.3 $0.44 8/15/202331,200 shares $11,544.00 -97.8%N/A0.1 $0.37 7/31/20231,390,000 shares $1.45 million +3,837.7%N/A5.6 $1.04 7/15/202335,300 shares $52,950.00 +13.1%N/A0.2 $1.50 6/30/202331,200 shares $45,552.00 +51.5%N/A0.6 $1.46 6/15/202320,600 shares $32,960.00 -59.7%N/A0.4 $1.60 5/31/202351,100 shares $79,716.00 -28.0%N/A1 $1.56 5/15/202371,000 shares $117,150.00 -47.6%N/A1.3 $1.65 4/30/2023135,500 shares $260,160.00 +47.8%N/A2.4 $1.92 4/15/202391,700 shares $174,230.00 -35.1%N/A1.6 $1.90 3/31/2023141,200 shares $287,342.00 +34.2%N/A2 $2.04 3/15/2023105,200 shares $190,412.00 -30.1%N/A1.2 $1.81 2/28/2023150,400 shares $318,848.00 +118.6%N/A0.2 $2.12 2/15/202368,800 shares $141,040.00 -49.1%N/A0.1 $2.05 1/31/2023135,100 shares $310,730.00 -27.3%N/A0.2 $2.30 1/15/2023185,800 shares $418,050.00 -32.3%N/A0.2 $2.25 12/30/2022274,500 shares $636,840.00 -38.8%N/A0.4 $2.32 12/15/2022448,700 shares $1.01 million +764.6%N/A0.6 $2.25 11/30/202251,900 shares $161,928.00 -2.8%N/A1.5 $3.12 11/15/202253,400 shares $178,890.00 -12.3%N/A1.5 $3.35 10/31/202260,900 shares $183,918.00 +6.8%N/A1.3 $3.02 10/15/202257,000 shares $161,310.00 +8.6%N/A0.9 $2.83 9/30/202252,500 shares $159,600.00 +23.8%N/A0.9 $3.04Most people would never touch this orange powder… would you? (Ad)At first glance, it looks like some ordinary “orange” powder… But in reality, it is a scientific breakthrough in energy technology. One that could wipe out fossil fuel, coal, and even the “glorified” renewable energy in just a few years. And right now, governments, institutions, and the elites are jumping on this resource at record pace to the point where we’re starting to run out. The question is… Why are the top 1% piling in this much? And more importantly, what will be the implications of this act by the elites on YOU and of course, the stock market?Well, all the answers you need are right here 9/15/202242,400 shares $158,576.00 +3.9%N/A0.7 $3.74 8/31/202240,800 shares $144,432.00 -4.5%N/A0.4 $3.54 8/15/202242,700 shares $195,993.00 -48.9%N/A0.5 $4.59 7/31/202283,500 shares $328,990.00 -9.3%N/A1 $3.94 7/15/202292,100 shares $361,032.00 -30.2%N/A1.3 $3.92 6/30/2022132,000 shares $472,560.00 -24.8%N/A1.4 $3.58 6/15/2022175,600 shares $579,480.00 +20.9%N/A0.8 $3.30 5/31/2022145,200 shares $665,016.00 +1.0%N/A0.7 $4.58 5/15/2022143,700 shares $661,020.00 -13.4%N/A0.7 $4.60 4/30/2022165,900 shares $706,734.00 -12.2%N/A0.7 $4.26 4/15/2022188,900 shares $899,164.00 -6.3%N/A0.7 $4.76 3/31/2022201,600 shares $1.18 million +39.5%N/A0.8 $5.87 3/15/2022144,500 shares $647,360.00 +1.4%N/A1 $4.48 2/28/2022142,500 shares $820,800.00 -19.4%N/A0.6 $5.76 2/15/2022176,800 shares $1.11 million +247.4%N/A0.1 $6.29 1/31/202250,900 shares $297,256.00 -65.8%N/A0 $5.84 1/15/2022148,600 shares $1.07 million -35.3%N/A0 $7.22 12/31/2021229,500 shares $1.81 million -25.8%N/A0.1 $7.87 12/15/2021309,400 shares $2.44 million -72.4%N/A0.1 $7.90 11/30/20211,120,000 shares $11.16 million +1,182.9%N/A0.3 $9.96 11/15/202187,300 shares $848,556.00 +4.9%N/A0 $9.72 10/29/202183,200 shares $1.27 million +32.3%N/A1.6 $15.24 10/15/202162,900 shares $942,871.00 +4.7%N/A1.4 $14.99 9/30/202160,100 shares $927,944.00 -6.1%N/A1.2 $15.44 9/15/202164,000 shares $1.10 million -13.9%N/A1.2 $17.14 8/31/202174,300 shares $1.33 million -20.8%N/A1 $17.95 8/13/202193,800 shares $1.59 million -1.7%N/A1.2 $17.00 7/30/202195,400 shares $1.79 million -9.2%2.3%1.3 $18.77 7/15/2021105,100 shares $1.87 million -5.0%2.5%1.4 $17.75 6/30/2021110,600 shares $2.48 million +5.2%2.7%1.5 $22.43 6/15/2021105,100 shares $3.15 million -10.0%2.5%1.6 $30.00 5/28/2021116,800 shares $3.05 million +15.3%2.8%2.5 $26.12 5/14/2021101,300 shares $2.22 million -24.7%2.4%2.5 $21.93 4/30/2021134,600 shares $3.68 million +1.4%3.2%2.9 $27.34 4/15/2021132,800 shares $3.40 million -9.8%3.3%2.5 $25.57 3/31/2021147,300 shares $4.15 million -19.8%3.6%2.3 $28.20 3/15/2021183,600 shares $6.60 million -8.4%4.6%2.6 $35.97 2/26/2021200,500 shares $6.34 million +21.0%5.0%2.6 $31.62 2/12/2021165,700 shares $6.09 million +19.1%4.1%1.7 $36.76 1/29/2021139,100 shares $4.84 million +11.0%3.5%0.2 $34.83 1/15/2021125,300 shares $4.24 million -18.1%3.1%0.1 $33.82 12/31/2020153,000 shares $5.68 million -7.7%3.8%0.1 $37.11 12/15/2020165,800 shares $6.90 million -40.1%4.2%0.1 $41.61 11/30/2020276,700 shares $12.28 million -71.0%7.5%0.2 $44.39 11/15/2020955,400 shares $42.97 million +999.4%25.9%0.6 $44.98 10/30/202086,900 shares $572,671.00 +2.4%3.0%0.1 $6.59 10/15/202084,900 shares $594,300.00 -15.1%3.0%1.6 $7.00 9/30/2020100,000 shares $760,000.00 +33.7%3.5%1.2 $7.60 9/15/202074,800 shares $596,156.00 +9.2%2.6%0.1 $7.97 8/31/202068,500 shares $537,040.00 -20.3%2.4%0.1 $7.84Most people would never touch this orange powder… would you? (Ad)At first glance, it looks like some ordinary “orange” powder… But in reality, it is a scientific breakthrough in energy technology. One that could wipe out fossil fuel, coal, and even the “glorified” renewable energy in just a few years. And right now, governments, institutions, and the elites are jumping on this resource at record pace to the point where we’re starting to run out. The question is… Why are the top 1% piling in this much? And more importantly, what will be the implications of this act by the elites on YOU and of course, the stock market?Well, all the answers you need are right here 8/14/202085,900 shares $684,623.00 +39.7%3.0%0.1 $7.97 7/31/202061,500 shares $516,600.00 +27.6%2.1%0.1 $8.40 7/15/202048,200 shares $352,342.00 -75.1%1.7%0.1 $7.31 6/30/2020193,600 shares $1.62 million +147.6%6.7%0.3 $8.35 6/15/202078,200 shares $420,716.00 -0.4%2.7%0.8 $5.38 5/29/202078,500 shares $466,290.00 -3.8%2.7%0.6 $5.94 5/15/202081,600 shares $446,352.00 +54.0%2.8%0.6 $5.47 4/30/202053,000 shares $265,000.00 -8.5%1.8%0.4 $5.00 4/15/202057,900 shares $242,022.00 +2.1%2.0%0.7 $4.18 3/31/202056,700 shares $242,676.00 -93.8%2.0%0.7 $4.28 3/13/2020918,900 shares $3.53 million -44.3%2.3%0.3 $3.84 2/28/20201,650,000 shares $429,000.00 +36.4%4.1%2.8 $0.26 2/14/20201,210,000 shares $435,600.00 +10.0%3.0%2.9 $0.36 1/31/20201,100,000 shares $484,000.00 -26.7%2.7%2.9 $0.44 1/15/20201,500,000 shares $765,000.00 -10.7%3.7%4.1 $0.51 12/31/20191,680,000 shares $1.08 million -2.9%4.2%4.7 $0.64 APVO Short Interest - Frequently Asked Questions What is Aptevo Therapeutics' current short interest? Short interest is the volume of Aptevo Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 54,000 shares of APVO short. 1.33% of Aptevo Therapeutics' shares are currently sold short. Learn More on Aptevo Therapeutics' current short interest. Which institutional investors are shorting Aptevo Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aptevo Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Aptevo Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.33% of Aptevo Therapeutics' floating shares are currently sold short. Is Aptevo Therapeutics' short interest increasing or decreasing? Aptevo Therapeutics saw a drop in short interest in May. As of May 15th, there was short interest totaling 54,000 shares, a drop of 79.9% from the previous total of 268,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aptevo Therapeutics' float size? Aptevo Therapeutics currently has issued a total of 4,080,000 shares. Some of Aptevo Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aptevo Therapeutics currently has a public float of 4,070,000 shares. How does Aptevo Therapeutics' short interest compare to its competitors? 1.33% of Aptevo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Aptevo Therapeutics: Kiora Pharmaceuticals, Inc. (0.28%), Elevai Labs, Inc. (0.77%), Imunon, Inc. (3.80%), Kintara Therapeutics, Inc. (2.04%), Guardion Health Sciences, Inc. (14.30%), MIRA Pharmaceuticals, Inc. (0.15%), Vaccinex, Inc. (1.71%), Avalo Therapeutics, Inc. (8.07%), FSD Pharma Inc. (0.93%), Eterna Therapeutics Inc. (1.89%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Aptevo Therapeutics stock? Short selling APVO is an investing strategy that aims to generate trading profit from Aptevo Therapeutics as its price is falling. APVO shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aptevo Therapeutics? A short squeeze for Aptevo Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APVO, which in turn drives the price of the stock up even further. How often is Aptevo Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APVO, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: KPRX Short Interest Data ELAB Short Interest Data IMNN Short Interest Data KTRA Short Interest Data GHSI Short Interest Data MIRA Short Interest Data VCNX Short Interest Data AVTX Short Interest Data HUGE Short Interest Data ERNA Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APVO) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptevo Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptevo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.